Glazer Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.8 Billion distributed in 254 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Enstar Group LTD with a value of $243M, Spring Works Therapeutics, Inc. with a value of $193M, Blueprint Medicines Corp with a value of $171M, Dun & Bradstreet Holdings, Inc. with a value of $162M, and Skechers Usa Inc with a value of $151M.

Examining the 13F form we can see an increase of $635M in the current position value, from $2.16B to 2.8B.

Glazer Capital, LLC is based out at New York, NY

Below you can find more details about Glazer Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.8 Billion
Financial Services: $495 Million
Healthcare: $418 Million
Consumer Cyclical: $288 Million
Industrials: $206 Million
Technology: $174 Million
Basic Materials: $113 Million
Energy: $61.2 Million
Real Estate: $54.3 Million
Other: $27.9 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 254
  • Current Value $2.8 Billion
  • Prior Value $2.16 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 124 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 68 stocks
Track This Portfolio

Track Glazer Capital, LLC Portfolio

Follow Glazer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glazer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glazer Capital, LLC with notifications on news.